2
Clinical Trials associated with Rotavirus vaccine, inactivated(Institute of Medical Biology Chinese Academy of Medical Sciences)评价轮状病毒灭活疫苗(Vero 细胞)在 2~71 月龄人群中免疫原性和安全性的随机、双盲、安慰剂对照II期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the immunogenicity and safety of inactivated rotavirus vaccine (Vero cells) in people aged 2 to 71 months
评价轮状病毒灭活疫苗(Vero 细胞)在 7~71 月龄人群中以 0,28天免疫程序接种以及在2~6月龄人群中以0,28,56天免疫程序接种后的免疫原性、安全性及免疫持久性。
[Translation] To evaluate the immunogenicity, safety, and persistence of immunity of an inactivated rotavirus vaccine (Vero cell) administered on a 0, 28-day schedule in people aged 7-71 months and on a 0, 28, 56-day schedule in people aged 2-6 months.
/ Active, not recruitingPhase 1 评价轮状病毒灭活疫苗(Vero细胞)在健康人群中接种的安全性及初步观察免疫原性的随机、双盲、安慰剂对照Ⅰ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety of rotavirus inactivated vaccine (Vero cells) in healthy people and to preliminarily observe the immunogenicity
评价轮状病毒灭活疫苗在成人(18岁-49岁),青少年(6岁-17岁)和婴幼儿(2月龄-6月龄,7月龄-71月龄)健康人群的安全性及初步探索其免疫原性,为II期临床试验的剂量探索研究等提供参考。
[Translation] To evaluate the safety of inactivated rotavirus vaccine in healthy adults (18-49 years old), adolescents (6-17 years old) and infants (2-6 months old, 7-71 months old) and to preliminarily explore its immunogenicity, and to provide a reference for dose exploration studies in Phase II clinical trials.
100 Clinical Results associated with Rotavirus vaccine, inactivated(Institute of Medical Biology Chinese Academy of Medical Sciences)
100 Translational Medicine associated with Rotavirus vaccine, inactivated(Institute of Medical Biology Chinese Academy of Medical Sciences)
100 Patents (Medical) associated with Rotavirus vaccine, inactivated(Institute of Medical Biology Chinese Academy of Medical Sciences)
100 Deals associated with Rotavirus vaccine, inactivated(Institute of Medical Biology Chinese Academy of Medical Sciences)